Pamidronate therapy in children with osteogenesis imperfecta: Effect on the bone material level.

被引：0
|
作者：
Weber, M
Roschger, P
Rauch, F
Schoeberl, T
Fratzl-Zelman, N
Glorieux, FH
Fratzl, P
Klaushofer, K
机构：
[1] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Dept Med 4, Vienna, Austria
[2] UKH Meidling, Vienna, Austria
[3] Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada
[4] McGill Univ, Montreal, PQ, Canada
[5] Univ Leoben, Erich Schmid Inst Mat Sci, Austrian Acad Sci, Leoben, Austria
[6] Univ Leoben, Inst Met Phys, Leoben, Austria
[7] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [41] Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment
    Land, Christof
    Rauch, Frank
    Munns, Craig F.
    Sahebjam, Solmaz
    Glorieux, Francis H.
    BONE, 2006, 39 (04) : 901 - 906
  • [42] The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta Type V
    Zeitlin, L
    Rauch, F
    Travers, R
    Munns, C
    Glorieux, FH
    BONE, 2006, 38 (01) : 13 - 20
  • [43] Effect of alendronate therapy in children with osteogenesis imperfecta
    Vyskocil, V
    Pikner, R
    Kutílek, T
    JOINT BONE SPINE, 2005, 72 (05) : 416 - 423
  • [44] Increment of bone mass and diminution of bone fractures with oral pamidronate (APD) in children with osteogenesis imperfecta.
    Tau, CC
    Alvarez, V
    Mautalen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S483 - S483
  • [45] Musculoskeletal Functional Outcomes in Children With Osteogenesis Imperfecta: Associations With Disease Severity and Pamidronate Therapy
    Sousa, Ted
    Bompadre, Viviana
    White, Klane K.
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2014, 34 (01) : 118 - 122
  • [46] Bone Material Properties in Osteogenesis Imperfecta
    Bishop, Nick
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (04) : 699 - 708
  • [47] Pamidronate administration may result in anaemia in children with osteogenesis imperfecta
    Michalus, Izabela
    Nowicka, Zuzanna
    Pietras, Wiktoria Aleksandra
    Nowicka, Maja
    Jakubowska-Pietkiewicz, Elzbieta
    ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 (09) : 906 - +
  • [48] Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study
    Forin, W
    Arabi, A
    Guigonis, V
    Filipe, G
    Bensman, A
    Roux, C
    JOINT BONE SPINE, 2005, 72 (04) : 313 - 318
  • [49] EFFICACY OF PAMIDRONATE IN CHILDREN WITH OSTEOGENESIS IMPERFECTA: AN OPEN PROSPECTIVE STUDY
    El Rakaawi, M.
    Hammoumraoui, N.
    Mellal, S.
    Sadouki, F.
    Lehtihet, S.
    Kerri, W.
    Djoudi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 289 - 290
  • [50] Pamidronate treatment of less severe forms of osteogenesis imperfecta in children
    Zacharin, M
    Kanumakala, S
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2004, 17 (11): : 1511 - 1517
12345